The Atlas Arteria Group (ASX: ALX) share price is in focus today as Diamond Infraco 1 Pty Ltd, a subsidiary of IFM Global Infrastructure Fund, issued its sixth supplementary bidder’s statement extending its takeover offer and updating the status of offer conditions.
What did Atlas Arteria report?
- The offer period for Diamond Infraco’s takeover bid has been extended to 7:00pm (Sydney time) on Thursday, 25 June 2026.
- Several regulatory and material agreement conditions of the offer have been either fulfilled or waived.
- The bid remains subject to a small number of outstanding conditions, including no market fall and restrictions on distributions and major business changes.
- The new deadline for notice of the status of conditions is now 18 June 2026.
What else do investors need to know?
Diamond Infraco’s extension gives Atlas Arteria shareholders a further week to consider the bid, replacing the previous closing date of 18 June 2026. Most regulatory hurdles have now been cleared, which means the offer is closer to being unconditional.
At the time of the latest statement, only a handful of conditions remain. These largely relate to market performance and ensuring Atlas Arteria does not undertake significant changes before the offer closes. This update was formally lodged with the Australian Securities and Investments Commission on 10 June 2026.
What’s next for Atlas Arteria?
The focus now shifts to whether the remaining offer conditions are satisfied or waived ahead of the extended closing date. Shareholders can expect further updates by or before 18 June 2026 regarding the status of outstanding conditions.
Looking ahead, Atlas Arteria’s board and shareholders will be weighing up the merits of the revised timeline and any developments in negotiations with Diamond Infraco as the offer nears its new closing date.
Atlas Arteria share price snapshot
Over the past 12 months, Atlas Arteria shares have declined 4%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.
The post Atlas Arteria takeover bid extended appeared first on The Motley Fool Australia.
Should you invest $1,000 in Atlas Arteria right now?
Before you buy Atlas Arteria shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Atlas Arteria wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- 5 things to watch on the ASX 200 on Thursday
- Here are the top 10 ASX 200 shares today
- Average superannuation balance in Australia in 2026: 45 vs 65 year olds
- 5 things to watch on the ASX 200 on Wednesday
- Here are the top 10 ASX 200 shares today
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.